News: J&J Gets Consent Decree: FDA to Oversee Plants

Johnson & Johnson signed a consent decree with the Food and Drug Administration on Thursday that puts three key manufacturing plants under years of tight regulatory scrutiny, but doesn't levy any fines or shut down two of the three plants that are still running.
March 11, 2011
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates